Literature DB >> 1540484

Lack of effect of ageing on the stereochemical disposition of propranolol.

H H Zhou1, E Whelan, A J Wood.   

Abstract

The elderly are more resistant to the effects of propranolol than the young. To determine whether the decreased sensitivity in the elderly could be due to stereoselective alteration in propranolol metabolism, we investigated the effect of age on the oral clearance of (-)- and (+)-propranolol. Six young (aged 24-32, mean 27.3 +/- 1.3 years) and six elderly (65-80, mean 71.3 +/- 2.7 years) white male volunteers were given a single 80 mg oral dose of racemic propranolol. The mean peak plasma concentrations of both (+)- and (-)-propranolol were significantly higher (P less than 0.05) in the elderly (105.7 +/- 19.7 and 165.0 +/- 29.7 nmol l-1) compared with the young subjects (68.6 +/- 10.1 and 115.7 +/- 18.1 nmol l-1). The oral clearances of both (+)- and (-)-propranolol were significantly higher (P less than 0.05) in the young (6933 +/- 598 and 4554 +/- 372 ml min-1) than in the elderly (4548 +/- 712 and 2941 +/- 473 ml min-1). Age had no effect on the relative concentration of the two isomers. Thus, the ratio of (+)-propranolol to (-)-propranolol was 0.67 +/- 0.05 in the young compared with 0.65 +/- 0.02 in the elderly.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1540484      PMCID: PMC1381211          DOI: 10.1111/j.1365-2125.1992.tb04012.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  17 in total

1.  Reduced beta-adrenoceptor sensitivity in the elderly.

Authors:  R E Vestal; A J Wood; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1979-08       Impact factor: 6.875

2.  Age-related changes in liver size and hepatic blood flow. The influence on drug metabolism in the elderly.

Authors:  K W Woodhouse; H A Wynne
Journal:  Clin Pharmacokinet       Date:  1988-11       Impact factor: 6.447

3.  Effects of age and cigarette smoking on propranolol disposition.

Authors:  R E Vestal; A J Wood; R A Branch; D G Shand; G R Wilkinson
Journal:  Clin Pharmacol Ther       Date:  1979-07       Impact factor: 6.875

4.  The effect of ageing on the hepatic clearance of propranolol.

Authors:  C M Castleden; C F George
Journal:  Br J Clin Pharmacol       Date:  1979-01       Impact factor: 4.335

5.  The influence of age and gender on the stereoselective metabolism and pharmacokinetics of mephobarbital in humans.

Authors:  W D Hooper; M S Qing
Journal:  Clin Pharmacol Ther       Date:  1990-12       Impact factor: 6.875

6.  Decline in beta adrenergic receptor-mediated vascular relaxation with aging in man.

Authors:  H Y Pan; B B Hoffman; R A Pershe; T F Blaschke
Journal:  J Pharmacol Exp Ther       Date:  1986-12       Impact factor: 4.030

7.  Simultaneous determination of propranolol enantiomers in plasma by high-performance liquid chromatography with fluorescence detection.

Authors:  C Prakash; R P Koshakji; A J Wood; I A Blair
Journal:  J Pharm Sci       Date:  1989-09       Impact factor: 3.534

8.  Suppression of ventricular arrhythmias in man by d-propranolol independent of beta-adrenergic receptor blockade.

Authors:  K T Murray; C Reilly; R P Koshakji; D M Roden; M D Lineberry; A J Wood; L A Siddoway; J T Barbey; R L Woosley
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

9.  Differences in stereoselective disposition of propranolol do not explain sensitivity differences between white and Chinese subjects: correlation between the clearance of (-)- and (+)-propranolol.

Authors:  H H Zhou; A J Wood
Journal:  Clin Pharmacol Ther       Date:  1990-06       Impact factor: 6.875

10.  Effect of aging and cigarette smoking on antipyrine and indocyanine green elimination.

Authors:  A J Wood; R E Vestal; G R Wilkinson; R A Branch; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1979-07       Impact factor: 6.875

View more
  7 in total

Review 1.  Cardiovascular drug therapy in elderly patients: specific age-related pharmacokinetic, pharmacodynamic and therapeutic considerations.

Authors:  Arduino A Mangoni
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 2.  Pharmacokinetic Variability of Drugs Used for Prophylactic Treatment of Migraine.

Authors:  Peer Tfelt-Hansen; Frederik Nybye Ågesen; Agniezka Pavbro; Jacob Tfelt-Hansen
Journal:  CNS Drugs       Date:  2017-05       Impact factor: 5.749

Review 3.  Clinical pharmacokinetic considerations in the elderly. An update.

Authors:  M T Kinirons; P Crome
Journal:  Clin Pharmacokinet       Date:  1997-10       Impact factor: 6.447

Review 4.  Drug chirality and its clinical significance.

Authors:  A J Hutt; S C Tan
Journal:  Drugs       Date:  1996       Impact factor: 9.546

Review 5.  Pharmacokinetic studies in elderly people. Are they necessary?

Authors:  P Crome; R J Flanagan
Journal:  Clin Pharmacokinet       Date:  1994-04       Impact factor: 6.447

Review 6.  Use of beta-adrenoceptor antagonists in older patients with chronic obstructive pulmonary disease and cardiovascular co-morbidity: safety issues.

Authors:  Miranda R Andrus; Joyce V Loyed
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

7.  Entropic and enthalpic contributions to stereospecific ligand binding from enhanced sampling methods.

Authors:  Balder Lai; Gabor Nagy; Jose Antonio Garate; Chris Oostenbrink
Journal:  J Chem Inf Model       Date:  2014-01-09       Impact factor: 4.956

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.